Your search for supplemental oxygen returned 58 results

The FDA has approved the supplemental new drug applicationfor Orfadin (nitisinone capsules; Sobi) which allows for an extension of shelf life for the 20mg capsules from 24 months to 36 months.

The FDA has approved a supplemental new drug application (sNDA) for Delzicol (mesalamine) Delayed-Release Capsules for the treatment of mildly to moderately active ulcerative colitis in patients ≥5 years of age.

The Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Pentasa (mesalamine; Shire) regarding an update to its route of administration.

The top five pulmonology-related issues that physicians and patients should question have been released by the American College of Chest Physicians and American Thoracic Society (ATS) as part of the Choosing Wisely campaign.

This patient information fact sheet provides information on the definition, symptoms, causes, diagnostic tests, treatments, and self-help measures for anemia.

Patients with chronic, noncancer-related pain who received fentanyl buccal tablet had consistent short-term efficacy across clinically meaningful analgesia measures, according to results of a study presented at the American Pain Society’s 31st Annual Scientific Meeting.

The pharmacologic treatment of schizophrenia and bipolar disorder leaves much to be desired. Repurposed drugs, which are approved for other medical conditions, represent an underutilized therapeutic resource for patients who have not responded to other drugs.

FibroGen announced data from its Phase 2a study of FG-4592 (oral anemia therapy) in patients with stage 3-4 chronic kidney disease (CKD) and anemia.